Research Advocacy

Research Advocacy is one way for people to become advocates by helping shape research. Ovarian cancer research advocates help researchers understand the questions that are important to the ovarian cancer community and ensure that research funded is a priority and carried out in a way that is as patient-friendly as possible. Research advocates also report back to the community, sharing what they have learned, so that everyone can benefit from scientific progress.

On this page you will find information about what research advocacy is, how to get involved and read reports from Alliance research advocates.

******************************************************************

Learn More about Research Advocacy

Research Advocate Training Programs

How to be a Research Advocate with the Alliance

  • Contact the Alliance to be added to our distribution list for opportunities (email ocna at ovariancancer dot org with subject line “Research Advocate”)
  • When you receive them, respond to requests the Alliance sends for Research Advocates
  • Participate in panels or meetings as required
  • Report back to the Alliance regarding the meeting or /panel you attended, including a brief written summary of the event

Resources

Reports from Ovarian Cancer National Alliance Research Advocates

  • Report from the Gynecologic Oncology Group Meeting in July Laurel Pracht.
  • Report from the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting (Patsy Hinson, Susan Leighton, Regina Parker, Alison Silberman, Cara Tenenbaum and Cheryl Trepagnier)
  • Report from the 2013 American Association of Cancer Researchers (AACR) Meeting (Susan Leighton)
  • Report from the June 2013 Society for Nuclear Medicine and Molecular Imaging Advocate (Laurel Pracht)
  • Report from the September 2012: DoD Ovarian Cancer Research Program Consumer Review (Annie Ellis)
  • Report from the March 2012: Annual Meeting of The Society of Gynecologic Oncology
    (Annie Ellis)
  • In this webinar, the Alliance reports on key research presented at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting
  • Report from the 2012 Cancer Survivorship Conference (Susan Leighton)
  • Report from the 2011 ASCO Annual Meeting